Login / Signup

Development and Validation of a Japanese Version of the Inflammatory Bowel Disease Self-efficacy Scale and Cross-culture Study in Japan and the United States.

Makoto TanakaAki KawakamiKayoko SakagamiTomoko TeraiJovelle FernandezLaurie KeeferHiroaki Ito
Published in: Inflammatory bowel diseases (2022)
The study demonstrates the reliability and validity of the IBD-SESJ. Self-efficacy scores for most items in Japanese patients were lower than those of patients in the United States. Further investigation is required to understand cross-cultural score differences.
Keyphrases
  • end stage renal disease
  • chronic kidney disease
  • newly diagnosed
  • prognostic factors
  • patient reported